Ketamine is a powerful anesthetic and dissociative drug that alters how your brain processes signals, producing effects that range from mild floating sensations at low doses to complete detachment from your body and surroundings at high doses. It also temporarily raises your heart rate and blood pressure. Originally developed for surgical anesthesia in the 1960s, ketamine is now also used to treat severe depression, and it remains one of the most widely used recreational dissociative drugs in the world.
How Ketamine Works in Your Brain
Ketamine blocks a specific type of receptor in your brain called the NMDA receptor. These receptors normally allow signals to pass between nerve cells when triggered by glutamate, the brain’s primary excitatory chemical messenger. Ketamine physically lodges itself inside the channel that these receptors use to transmit signals, effectively plugging it shut.
What happens next is counterintuitive. By blocking receptors on certain inhibitory brain cells (the ones that normally act as brakes on brain activity), ketamine actually increases overall brain activity. With the brakes partially disabled, excitatory neurons fire more freely and glutamate levels surge. This burst of activity is thought to trigger rapid growth of new connections between nerve cells, which helps explain why ketamine can relieve depression within hours rather than the weeks that conventional antidepressants require.
What It Feels Like
The psychological experience of ketamine depends heavily on the dose. At lower, sub-anesthetic doses, people commonly report feeling strange, spacey, woozy, floating, or loopy. Colors may look more vivid, sounds may seem distorted, and your sense of time can stretch or compress unpredictably.
At moderate doses, two distinct phenomena emerge. Derealization makes your surroundings feel unfamiliar or dreamlike, as though you’re watching the world through a screen. Depersonalization makes you feel disconnected from your own body and thoughts. Your perception of your physical form, the environment, and the passage of time all shift noticeably. Some people describe this as pleasant and even profound. Others find it disorienting or frightening.
At high doses, the experience intensifies into what recreational users call a “K-hole,” a state of near-total dissociation. The most commonly reported features include feeling like you’re melting into your surroundings, vivid visual hallucinations, and out-of-body experiences. Two-thirds of users in one study described these as the most appealing aspects of ketamine. On the other side, about half of users reported memory loss and reduced ability to socialize as the least appealing effects.
Physical Effects on Your Body
Ketamine stimulates your sympathetic nervous system, the same system responsible for your fight-or-flight response. This produces mild to moderate increases in blood pressure, heart rate, and the amount of blood your heart pumps with each beat. These changes are typically temporary and resolve as the drug wears off.
Unlike most other anesthetics, ketamine generally preserves your ability to breathe on your own, which is one reason it remains valuable in emergency medicine. You may experience nausea, dizziness, or blurred vision. Some people have what’s called an emergence reaction as the drug wears off, which can include hallucinations, panic, rapid heartbeat, and spikes in blood pressure.
How Quickly It Hits and How Long It Lasts
The route of administration changes everything about the timeline. Injected directly into a vein, ketamine takes effect within about one minute. Through the nose, onset takes roughly 3 to 12 minutes, with blood levels peaking around 18 to 21 minutes. The total duration of noticeable effects varies widely. Nasal ketamine used as a single dose typically lasts 7 to 69 minutes depending on the amount, with higher doses extending the experience considerably.
When used in clinical settings for depression, a standard intravenous infusion lasts about 40 minutes. The dissociative effects largely clear within an hour or two after the infusion ends, though some grogginess can linger for the rest of the day.
Ketamine for Depression
Ketamine’s most remarkable medical development in recent decades is its use against treatment-resistant depression, meaning depression that hasn’t responded to multiple standard medications. The speed of its antidepressant effect is unlike anything else in psychiatry.
In clinical studies, 65% to 71% of patients with treatment-resistant depression met response criteria (at least a 50% reduction in symptom scores) within 24 hours of a single infusion. Some patients experienced up to an 89% improvement in depression scores. A course of six infusions over 12 days produced a response rate of about 71%. The catch is that the relief doesn’t last indefinitely on its own. The median time to relapse after the last infusion was 18 days, though sustained remission lasting three months has been documented in some cases.
In 2019, the FDA approved a nasal spray form called esketamine (Spravato) for adults with treatment-resistant depression and for those with major depression accompanied by suicidal thoughts. It must be used alongside a conventional oral antidepressant and administered in a certified healthcare setting where patients are monitored for at least two hours afterward. Ketamine itself remains FDA-approved only as a general anesthetic, though many clinics offer off-label intravenous infusions for depression.
Risks of Repeated or Heavy Use
Occasional supervised medical use carries a different risk profile than frequent recreational use. The most serious long-term consequence of heavy, chronic ketamine use is severe damage to the urinary tract. A condition called ketamine-induced cystitis causes urinary pain and discomfort, deterioration of the bladder’s protective lining, thickening and scarring of the bladder wall, and reduced bladder capacity. In severe cases, the ureters (tubes connecting the kidneys to the bladder) can narrow and block urine flow, leading to kidney swelling and, eventually, chronic kidney failure.
Cognitive function also takes a hit with chronic use. Studies comparing regular ketamine users to healthy controls have found significant impairments in verbal and visual memory and in executive function, the mental skills you rely on for planning, decision-making, and impulse control. Executive dysfunction in chronic users has been linked to higher dropout rates from treatment programs, creating a cycle that makes recovery harder.
Psychological dependence is another concern. While ketamine doesn’t produce the severe physical withdrawal seen with alcohol or opioids, regular users can develop tolerance (needing higher doses for the same effect) and strong cravings that drive compulsive use patterns.
Medical Uses Beyond Depression
Ketamine’s original and still most established role is as an anesthetic, particularly useful in emergency rooms, battlefield medicine, and pediatric procedures. For children, intramuscular doses in the range of 4 to 5 mg/kg produce adequate sedation in 93% to 100% of cases. Its ability to maintain breathing reflexes and stable blood pressure makes it safer than many alternatives in situations where advanced airway equipment isn’t available.
It’s also used for acute pain management, particularly for patients who can’t tolerate opioids, and is being studied for conditions including post-traumatic stress disorder, obsessive-compulsive disorder, and substance use disorders. At sub-anesthetic doses, it provides powerful pain relief without the respiratory depression that makes opioids dangerous.